BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3937475)

  • 1. [Pseudomonas aeruginosa in dermatology].
    el Baze P; Lacour JP; Ortonne JP
    Ann Dermatol Venereol; 1985; 112(11):925-34. PubMed ID: 3937475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interdigital intertrigo of the foot].
    González-Rupérez J
    Enferm Infecc Microbiol Clin; 1997 May; 15(5):271-2. PubMed ID: 9376388
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients.
    Ionescu A; Meitert E; Vasiliu S; Meitert T; Sima F; Savulian C; Milicescu S
    Arch Roum Pathol Exp Microbiol; 1981; 40(4):323-32. PubMed ID: 6803737
    [No Abstract]   [Full Text] [Related]  

  • 4. Pseudomonas aeruginosa infections in a skin ward.
    Savin JA
    Trans St Johns Hosp Dermatol Soc; 1967; 53(1):75-9. PubMed ID: 4965905
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pseudomonas aeruginosa in dermatology].
    Morand A; Morand JJ
    Ann Dermatol Venereol; 2017 Nov; 144(11):666-675. PubMed ID: 28778416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired function of polymorphonuclear leukocytes in patients with burns and other trauma.
    Grogan JB; Miller RC
    Surg Gynecol Obstet; 1973 Nov; 137(5):784-8. PubMed ID: 4201002
    [No Abstract]   [Full Text] [Related]  

  • 7. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
    Moroz AF; Kharitonova AM; Chanturiia TsK
    Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa: clinical manifestations and management.
    Gould IM; Wise R
    Lancet; 1985 Nov; 2(8466):1224-7. PubMed ID: 2866300
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutical pseudomonas aeruginosa antisera. Preparation, control and administration.
    Meitert T; Meitert E; Szegli G; Peligrad I
    Arch Roum Pathol Exp Microbiol; 1982; 41(2):115-21. PubMed ID: 6816189
    [No Abstract]   [Full Text] [Related]  

  • 10. [Infection of crural ulcers with Pseudomonas aeruginosa in a dermatological clinic. A study of the role of some potentially infectious strains].
    Verburgh-van Zwan N D; Siem TH
    Ned Tijdschr Geneeskd; 1973 Apr; 117(16):631-7. PubMed ID: 4199833
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proceedings: II. Pyocyaneus infection. a. Prevention and therapy. Significance of Bacterium pyocyaneum (Ps. aeruginosa) from the bacteriologic viewpoint].
    Linzenmeier G
    Hefte Unfallheilkd; 1973; 114():123-7. PubMed ID: 4205706
    [No Abstract]   [Full Text] [Related]  

  • 12. Pseudomonas aeruginosa, hot tubs, and skin infections.
    Rasmussen JE; Graves WH
    Am J Dis Child; 1982 Jun; 136(6):553-4. PubMed ID: 7091072
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of ulcers infected by Pseudomonas aeruginosa or pyocyanic bacilli].
    Haven E; Deschilder J; Verhulst H; Coninx S
    Phlebologie; 1971; 24(4):349-56. PubMed ID: 5004878
    [No Abstract]   [Full Text] [Related]  

  • 14. Necrotizing fasciitis due to Pseudomonas aeruginosa in immuno-compromised children.
    Abbo O; Accadbled F; Guitard J; Galinier P; Plat-Willson G; Rubie H; Neven B
    Pediatr Blood Cancer; 2010 Jul; 55(1):213-4. PubMed ID: 20486189
    [No Abstract]   [Full Text] [Related]  

  • 15. Mono--and polyvalent Pseudomonas aeruginosa vaccines. Preparation, control and administration.
    Meitert E; Meitert T; Sima F; Savulian C
    Arch Roum Pathol Exp Microbiol; 1982; 41(2):105-14. PubMed ID: 6816188
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiological and immunobiological implications of Pseudomonas aeruginosa epidemiological markers.
    Meitert T; Meitert E
    Arch Roum Pathol Exp Microbiol; 1981; 40(1):5-23. PubMed ID: 6821022
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigation on the therapeutical efficiency of some adapted bacteriophages in experimental infection with Pseudomonas aeruginosa.
    Meitert E; Petrovici M; Sima F; Costache G; Savulian C
    Arch Roum Pathol Exp Microbiol; 1987; 46(1):17-26. PubMed ID: 3124795
    [No Abstract]   [Full Text] [Related]  

  • 18. Microbiologic evaluation of skin wounds: alarming trend toward antibiotic resistance in an inpatient dermatology service during a 10-year period.
    Valencia IC; Kirsner RS; Kerdel FA
    J Am Acad Dermatol; 2004 Jun; 50(6):845-9. PubMed ID: 15153882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal Pseudomonas septicemia and vasculitis in a premature infant.
    Hughes JR; Newbould M; du Vivier AW; Greenough A
    Pediatr Dermatol; 1998; 15(2):122-4. PubMed ID: 9572696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Pseudomonas aeruginosa in infections.
    Neu HC
    J Antimicrob Chemother; 1983 May; 11 Suppl B():1-13. PubMed ID: 6413479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.